STOCK TITAN

BULLFROG AI HLDGS INC - BFRG STOCK NEWS

Welcome to our dedicated page for BULLFROG AI HLDGS news (Ticker: BFRG), a resource for investors and traders seeking the latest updates and insights on BULLFROG AI HLDGS stock.

BullFrog AI Holdings Inc. (NASDAQ: BFRG) is a biotechnology innovator using artificial intelligence to accelerate drug discovery and clinical development. This news hub provides investors and industry professionals with timely updates on the company's AI-driven research initiatives, strategic partnerships, and therapeutic advancements.

Access consolidated information on BFRG's latest press releases including clinical trial progress, regulatory milestones, and technology developments related to its proprietary bfLEAP platform. Our curated collection serves as an essential resource for tracking advancements in precision medicine and AI-powered pharmaceutical research.

Key updates cover therapeutic focus areas such as liver disease treatments, obesity research, and neuropsychiatric disorder solutions. Stay informed about collaborative projects with leading research institutions and data-driven breakthroughs in biomarker discovery.

Bookmark this page for direct access to BullFrog AI's official announcements and third-party analysis. Regularly updated content ensures you maintain current awareness of the company's position at the intersection of biotechnology and artificial intelligence innovation.

Rhea-AI Summary
BullFrog AI founder and CEO to give webinar presentation on the Company's use of machine learning in drug development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.76%
Tags
AI
-
Rhea-AI Summary
BullFrog AI's machine learning technology selected as finalist for R&D 100 Awards in IT/Electrical category
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.84%
Tags
AI
-
Rhea-AI Summary
BullFrog AI Holdings, Inc. announces the issuance of a US patent for its novel prodrugs derived from mebendazole. The compounds have improved solubility and oral bioavailability, addressing a key difficulty in evaluating mebendazole for oncology indications.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
44.22%
Tags
AI
Rhea-AI Summary
BullFrog AI appoints Enrique García-Rivera as VP of Artificial Intelligence to enhance development of bfLEAP™ AI platform for drug discovery.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.2%
Tags
management AI
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.24%
Tags
conferences AI
-
Rhea-AI Summary
BullFrog AI Holdings has appointed Toby Sayre as VP of Business Development. Sayre brings over 18 years of experience in life sciences and biotechnology consulting. He will play a crucial role in expanding the company's reach in the industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.09%
Tags
management AI
Rhea-AI Summary
BullFrog AI expands license agreement with Johns Hopkins Applied Physics Laboratory to use patented technology for its bfLEAP™ platform. The technology enables analysis of large and diverse datasets, detection of anomalies, and improved performance compared to benchmarking tests. The update brings robustness and usability improvements to the platform.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.85%
Tags
AI
-
Rhea-AI Summary
BullFrog AI Holdings has filed its Form 10-Q with the SEC for the quarter ended March 31, 2023. The company received a notice from Nasdaq regarding non-compliance with periodic filing requirements, but is now in compliance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.48%
Tags
AI
-
Rhea-AI Summary
BullFrog AI Holdings, Inc. CEO to present at JMP Securities Life Sciences Conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.75%
Tags
conferences AI
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.98%
Tags
conferences AI
BULLFROG AI HLDGS INC

Nasdaq:BFRG

BFRG Rankings

BFRG Stock Data

15.63M
6.97M
29.2%
11.72%
6.24%
Health Information Services
Pharmaceutical Preparations
Link
United States
GAITHERSBURG